MetaCap

Niki BioSolutions (NIKI) vs U Power (UCAR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

U Power is the larger company by market cap ($5.3 million vs $4.9 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

NIKI-66.24%UCAR-23.08%
+13%-29%-72%
Oct 7, 20261 yearNov 20, 2026
NIKI-60.75%UCAR-29.58%
+3%-30%-64%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

NIKI versus UCAR key metrics
MetricNIKIUCAR
Share price$1.57$3.00
Market cap$4.90M$5.32M
1-day change-6.55%0.00%
YTD return-85.19%—
1-year return-87.92%—
5-year return-99.18%—
EPS (TTM)$-2.90$-286.12
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$5.85M
Revenue growth (YoY)—-3.58%
Net income (latest FY)$-1.36M$-9.78M
Gross margin—36.27%
Operating margin—-141.67%
Net margin—-167.08%
52-week high$14.40$396.00
52-week low$1.42$2.34
Distance from 52-week high-89.10%-99.24%
Analyst consensus—none
Average volume97.67K17.72K
Shares outstanding2.94M1.77M
Employees186
SectorIndustrialsMiscellaneous
IndustryIndustrial Machinery/ComponentsIndustrial Machinery/Components

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • The two companies sit in different sectors: Niki BioSolutions in Industrials and U Power in Miscellaneous.

About Niki BioSolutions

NIKI stock →

Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa.

Industrials · Industrial Machinery/Components · 1 employees

About U Power

UCAR stock →

U Power Limited, together with its subsidiaries, develops, manufactures, and sells new energy vehicles and battery swapping stations in the People's Republic of China and internationally. It also provides battery swapping and sourcing, as well as technical and consultation services.

Miscellaneous · Industrial Machinery/Components · 86 employees

NIKI vs UCAR FAQ

Which is bigger, Niki BioSolutions or U Power?

U Power (UCAR) is larger, with a market capitalization of $5.32M compared with $4.90M for Niki BioSolutions (NIKI).

Are Niki BioSolutions and U Power in the same industry?

Yes. Both are classified in the Industrial Machinery/Components industry within the Industrials sector.

More comparisons